Adverse event reports following vaccination for Lyme disease: December 1998–July 2000
Sarah Lathrop(Washington and Lee University), Edward B. Hayes(Centers for Disease Control and Prevention), Sean V. Shadomy(Center for Biologics Evaluation and Research), Susan S. Ellenberg(University of Pennsylvania), Robert Ball(Center for Drug Evaluation and Research), Penina Haber, Robert T. Chen(The Task Force for Global Health), M. Miles Braun(Center for Biologics Evaluation and Research), Gina T. Mootrey
Cited by 93
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
|Arthritis & Rheumatism|2002|661
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
|Annals of Internal Medicine|2003|459
Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept
|Arthritis & Rheumatism|2002|448